Cancer News and Research

Latest Cancer News and Research

Low semen quality linked to shorter lifespan

Researchers determine how low semen quality may impact mortality risk.

10 Mar 2025

Why do some people need supplements and others don’t? New review explains

New research in The New England Journal of Medicine reviews current knowledge on micronutrient requirements, deficiencies, and interventions. It highlights the need for targeted supplementation and calls for advanced research to better diagnose and treat hidden deficiencies.

9 Mar 2025

GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 diabetes patients, especially compared to insulin. The study also highlights GLP-1RAs’ potential as a cancer-protective treatment, independent of glucose control.

9 Mar 2025

Understanding the role of LSD1 in cellular processes and disease

A new review highlights the pivotal role of LSD1 (lysine-specific demethylase 1) in regulating critical cellular processes and its implications for human diseases.

8 Mar 2025

Unraveling the genetic differences between LUAD and LUSC in lung cancer

Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) representing the most prevalent subtypes of non-small cell lung cancer (NSCLC).

8 Mar 2025

Circular RNA plays key role in cancer biology and therapy

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

8 Mar 2025

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.

8 Mar 2025

Study assesses two ways to test patients' hereditary cancer risks

Up to 10% of cancers are caused by genes that can be easily detected by commercially available tests. These include such common cancers as cancer of the breast, ovary, colon, stomach, uterus and pancreas.

8 Mar 2025

Ubiquitination plays a key role in cancer stem cell function and treatment resistance

This review highlights the critical role of ubiquitination in governing the functionality of cancer stem cells (CSCs), shedding light on potential therapeutic targets for combating tumor progression, recurrence, and drug resistance.

8 Mar 2025

EZH2 inhibition offers hope for fighting treatment-resistant cancers

The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published in Genes & Diseases.

8 Mar 2025

Eradivir begins Phase 2 challenge study for antiviral therapeutic EV25

Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and efficacy data gathered from otherwise healthy participants infected with influenza then later treated with EV25.

7 Mar 2025

Environmental research effort aims to improve health in Houston's vulnerable neighborhoods

Garett Sansom, DrPH, and Lindsay Sansom, PhD, with the Texas A&M University School of Public Health, have been named principal investigator and co-principal investigator of a new, one-year effort funded by the National Academies of Sciences, Engineering, and Medicine Gulf Research Program to evaluate soil conditions in two northeast Houston neighborhoods and foster community engagement by local residents.

7 Mar 2025

Breakthrough drug more than doubles survival in glioblastoma patients

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults.

7 Mar 2025

Insilico Medicine's AI-driven drug Rentosertib receives official generic name

Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic pulmonary fibrosis (IPF) – Rentosertib (formerly known as ISM001-055) – has been granted an official generic name by the United States Adopted Names (USAN) Council.

7 Mar 2025

Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against

Panelists at a covid conference last fall were asked to voice their regrets — policies they had supported during the pandemic but had come to see as misguided. Covid contact tracing, one said. Closing schools, another said. Vaccine mandates, a third said.

7 Mar 2025

AI-enhanced doctors: How new technology is transforming patient care, cutting errors, and freeing up NHS

The NHS and UK doctors are set to benefit from ground-breaking artificial intelligence technology designed to transform the way doctors interact with patients, reducing medical errors, cutting administrative burdens, and making thousands of additional appointments available.

7 Mar 2025

Swapping butter with plant-based oils in daily diet could lead to significant health benefits

People who consume plant-based oil instead of butter may experience beneficial health effects and even have a lower risk of premature death, according to a new study by investigators from Mass General Brigham, Harvard T.H. Chan School of Public Health, and the Broad Institute of MIT and Harvard.

7 Mar 2025

Novel treatment approach shows promise for advanced HPV-negative head and neck cancer

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC).

7 Mar 2025

Research poses a new explanation for how cancer-fighting drugs attack and destroy tumor cells

Research by UMass Chan Medical School scientists Sharon Cantor, PhD, and Jenna M. Whalen, PhD, poses a new explanation for how cancer-fighting drugs attack and destroy BRCA1 and BRCA2 tumor cells.

7 Mar 2025

Partial gland cryoablation offers long-term success for prostate cancer patients

A five-year study on men that had just the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual function.

6 Mar 2025

Cancer News and Research

Latest Cancer News and Research

Low semen quality linked to shorter lifespan

Why do some people need supplements and others don’t? New review explains

GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients

Understanding the role of LSD1 in cellular processes and disease

Unraveling the genetic differences between LUAD and LUSC in lung cancer

Circular RNA plays key role in cancer biology and therapy

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

Study assesses two ways to test patients' hereditary cancer risks

Ubiquitination plays a key role in cancer stem cell function and treatment resistance

EZH2 inhibition offers hope for fighting treatment-resistant cancers

Eradivir begins Phase 2 challenge study for antiviral therapeutic EV25

Environmental research effort aims to improve health in Houston's vulnerable neighborhoods

Breakthrough drug more than doubles survival in glioblastoma patients

Insilico Medicine's AI-driven drug Rentosertib receives official generic name

Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against

AI-enhanced doctors: How new technology is transforming patient care, cutting errors, and freeing up NHS

Swapping butter with plant-based oils in daily diet could lead to significant health benefits

Novel treatment approach shows promise for advanced HPV-negative head and neck cancer

Research poses a new explanation for how cancer-fighting drugs attack and destroy tumor cells

Partial gland cryoablation offers long-term success for prostate cancer patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in